The Centers for Medicare & Medicaid Services late this afternoon issued a final rule on the notice of benefit and payment parameters standards for health insurance issuers and the Health Insurance Marketplaces in 2018. The rule sets forth the payment parameters and provisions related to the risk-adjustment program; cost-sharing parameters and cost-sharing reductions; and user fees for federally-facilitated exchanges and state-based exchanges on the federal platform. CMS finalized several changes with respect to the risk-adjustment program, including better accounting for partial-year enrollments and using prescription drug data as one source of information on diagnoses. CMS also finalized policies with respect to expanding the number of standardized plan options available; applying cost sharing resulting from bills from out-of-network providers at in-network facilities toward the cost sharing limits in off-exchange products; and incorporating an “integrated delivery system” identifier into plan listings to help consumers identify plans, among other related topics. The provisions in the rule will be effective 30 days after publication in the Federal Register. For more information, see the CMS factsheet. AHA members will receive a Special Bulletin with further details next week.

Perspective
Public
Approximately 35 million Americans are enrolled in Medicare Advantage plans in 2026, and that number is expected to grow to about 45 million MA enrollees by…
Headline
The Centers for Medicare & Medicaid Services has released details on downloading its upcoming fiscal year 2025 Program for Evaluating Payment Patterns…
Headline
The Department of Health and Human Services Administration for Community Living has launched the first phase of its Health at Home Challenge, a competition to…
Headline
The AHA shared the following statement with the media in response to a report released May 7 by Families USA.   “This report is long on rhetoric and…
Headline
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S. 4384), bipartisan and bicameral…
Headline
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible…